Effective treatment with oral sulfonylureas in patients with diabetes due to SUR1 Mutations

Benzer Materyaller

• Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetes
  Yazar:: Babiker, Tarig, ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• Sulfonylurea Treatment in Young Children with Neonatal Diabetes: Dealing with Hyperglycaemia, Hypoglycaemia and Sickdays
  Yazar:: Codner, Ethel, ve diğerleri
  Baskı/Yayın Bilgisi: (2007)
• Mutations in the ABCC8 gene encoding the SUR1 subunit of the K(ATP) channel cause transient neonatal diabetes, permanent neonatal diabetes or permanent diabetes diagnosed outside the neonatal period
  Yazar:: Patch, A.M., ve diğerleri
  Baskı/Yayın Bilgisi: (2007)
• Mutations of the Same Conserved Glutamate Residue in NBD2 of the Sulfonylurea Receptor 1 Subunit of the K(ATP) Channel Can Result in Either Hyperinsulinism or Neonatal Diabetes
  Yazar:: Männikkö, Roope, ve diğerleri
  Baskı/Yayın Bilgisi: (2011)
• Permanent Neonatal Diabetes Caused by Dominant, Recessive, or Compound Heterozygous SUR1 Mutations with Opposite Functional Effects
  Yazar:: Ellard, Sian , ve diğerleri
  Baskı/Yayın Bilgisi: (2007)